Stress Urinary Incontinence and Sarcopenia in Postmenopausal Osteoporosis

Last updated: December 9, 2024
Sponsor: Beylikduzu State Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Osteoporosis

Sarcopenia

Enuresis

Treatment

No intervention

Clinical Study ID

NCT06655701
BeylikduzuStateH8
  • Ages 50-75
  • Female
  • Accepts Healthy Volunteers

Study Summary

The primary aim of our study is to evaluate the presence of stress urinary incontinence in postmenopausal patients with and without osteoporosis, determine its impact on quality of life, and explore its relationship with sarcopenia.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Postmenopausal women with DXA measurements performed within the last 6 months.

  • Based on DXA measurements:

Femoral neck and L1-L4 T-scores of -1 and above will be included in the control group (non-osteoporotic).

Femoral neck and L1-L4 T-scores of -2.5 and below will be included in the osteoporosis group.

  • Aged 50-75 years

Exclusion

Exclusion Criteria:

  • Refusal to participate in the study.

  • History of neurological diseases, infections, surgeries, or trauma that could causeurinary incontinence or muscle loss.

  • Presence of psychiatric disorders.

  • Cognitive impairments.

  • Use of medications that could affect the study results.

Study Design

Total Participants: 100
Treatment Group(s): 1
Primary Treatment: No intervention
Phase:
Study Start date:
November 15, 2024
Estimated Completion Date:
January 15, 2025

Study Description

One hundred postmenopausal women, aged 50-75, who applied to the Physical Therapy and Rehabilitation outpatient clinic at Beylikdüzü State Hospital and have Dual-X-ray Absorptiometry (DXA) measurements taken within the last 6 months, including both osteoporotic and non-osteoporotic patients, will be included in the study. Sociodemographic data such as age, gender, height, weight, and BMI will be recorded. DXA results, including femoral neck and L1-L4 T-scores and BMD values, will be obtained. Patients will be asked about osteoporosis treatment, presence of fecal incontinence, constipation, and medication use. Stress urinary incontinence will be determined through a questionnaire, and its impact on quality of life will be assessed using the Incontinence Quality of Life Scale. In the second phase, sarcopenia will be evaluated according to the Asian Working Group for Sarcopenia (AWGS) criteria by assessing skeletal muscle mass (via bioelectrical impedance analysis), handgrip strength, and the 5-times sit-to-stand test.

Connect with a study center

  • Beylikdüzü State Hospital

    Istanbul, 34147
    Turkey

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.